ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 117 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $949,000 | +190.2% | 50,360 | +81.0% | 0.00% | – |
| Q2 2019 | $327,000 | -3.5% | 27,821 | +12.0% | 0.00% | – |
| Q1 2019 | $339,000 | +33.5% | 24,842 | 0.0% | 0.00% | – |
| Q4 2018 | $254,000 | -34.0% | 24,842 | +7.3% | 0.00% | – |
| Q3 2018 | $385,000 | +5.2% | 23,144 | 0.0% | 0.00% | – |
| Q2 2018 | $366,000 | +13.0% | 23,144 | -9.4% | 0.00% | – |
| Q1 2018 | $324,000 | +45.3% | 25,547 | +31.1% | 0.00% | – |
| Q4 2017 | $223,000 | -3.5% | 19,487 | +2.5% | 0.00% | – |
| Q3 2017 | $231,000 | +30.5% | 19,011 | +22.7% | 0.00% | – |
| Q2 2017 | $177,000 | -44.0% | 15,496 | +2.6% | 0.00% | – |
| Q1 2017 | $316,000 | -0.6% | 15,096 | -1.3% | 0.00% | – |
| Q4 2016 | $318,000 | -1.2% | 15,289 | +51.6% | 0.00% | – |
| Q3 2016 | $322,000 | +17.5% | 10,087 | -9.7% | 0.00% | – |
| Q2 2016 | $274,000 | +35.0% | 11,171 | +33.8% | 0.00% | – |
| Q1 2016 | $203,000 | +14.7% | 8,349 | +57.6% | 0.00% | – |
| Q4 2015 | $177,000 | +25.5% | 5,296 | +16.2% | 0.00% | – |
| Q3 2015 | $141,000 | -15.1% | 4,556 | +34.2% | 0.00% | – |
| Q2 2015 | $166,000 | +418.8% | 3,396 | +214.4% | 0.00% | – |
| Q1 2015 | $32,000 | – | 1,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |